The Indian Small and Medium Enterprise (SME) primary market continues to show notable activity. The latest company preparing to enter the public arena is Kanpur-based industrial manufacturer Anubhav Plast Limited. The company has finalized its IPO timeline, scheduling its subscription bidding window to open on Friday, June 19, 2026, and close on Tuesday, June 23, […]

The Indian Small and Medium Enterprise (SME) primary market is witnessing massive momentum in the consumer discretionary and lifestyle apparel space. Driven by a powerful post-pandemic revival in regional wedding economies and a structural shift toward organized boutique retail, ethnic wear brands are aggressively raising public funds. The latest brand entering the public market is

The Indian automobile sector has entered a massive structural transition. The two-wheeler segment is no longer a simple market for low-cost commuter bikes. Driven by rising urban incomes, a powerful post-harvest rural recovery, and an aggressive shift toward clean energy, the industry is witnessing a massive battle across two core fronts: high-margin premium performance bikes

The Indian fintech and insurtech landscapes are witnessing an aggressive wave of primary market entries. Following the confidential pre-filing route that defined several late-2025 consumer-tech draft prospects, Turtlemint Fintech Solutions Limited has officially filed its Red Herring Prospectus (RHP) with SEBI. The Mumbai-headquartered platform has scheduled its initial public offering (IPO) subscription window to launch

The Indian naval defense and shipbuilding industry is undergoing a historic structural transformation. Driven by the “Atmanirbhar Bharat” initiative—which mandates that up to 90% of structural naval components and vessel hulls be sourced from domestic vendors—the sector has transformed from a slow utility niche into a high-octane wealth generator. While global maritime yards are growing

The Indian pharmaceutical sector has undergone a structural transformation. The historic baseline of relying on low-margin, small-molecule commodity generic exports to highly regulated western markets has given way to high-barrier domestic frameworks. Driven by an aging population, rising disposable incomes, and increasing awareness of chronic lifestyle conditions, the domestic Indian Pharmaceutical Market (IPM) is now

India’s pledge to build 500 GW of renewable energy capacity by 2030 has triggered a massive scale-up across the nation’s power infrastructure. Building massive solar and wind installations in remote deserts or coastlines is useless without the grid infrastructure required to evacuate that clean power to high-density industrial hubs. This massive green energy transition has